References
Schiffer CA, Hehlmann R, Larson R . Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1). Leukemia 2003; 17: 691–699.
Savage DG, Antman KH . Imatinib mesylate – a new oral targeted therapy. N Engl J Med 2002; 346: 683–693.
Valeyrie L, Bastuji-Garin S, Revuz J, Bachot N, Wechsler J, Berthaud P et al. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol 2003; 48: 201–206.
Lindahl P, Johansson BR, Leveen P, Betsholtz C . Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997; 277: 242–245.
Koleske AJ, Gifford AM, Scott ML, Nee M, Bronson RT, Miczek KA et al. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 1998; 21: 1259–1272.
Fraunfelder FW, Solomon J, Druker BJ, Esmaeli B, Kuyl J . Ocular side-effects associated with imatinib mesylate (Gleevec). J Ocul Pharmacol Ther 2003; 19: 371–375.
Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994; 35: 3649–3663.
Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344: 1052–1056.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kusumi, E., Arakawa, A., Kami, M. et al. Visual disturbance due to retinal edema as a complication of imatinib. Leukemia 18, 1138–1139 (2004). https://doi.org/10.1038/sj.leu.2403364
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403364
- Springer Nature Limited
This article is cited by
-
Ocular Toxicity of Targeted Anticancer Agents
Drugs (2021)
-
Drug-Induced Macular Edema
Drugs (2013)
-
Bilateral papilledema on sunitinib therapy for advanced renal cell carcinoma
Medical Oncology (2011)
-
Optic disc edema as a possible complication of Imatinib mesylate (Gleevec)
Japanese Journal of Ophthalmology (2008)
-
Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect
Graefe's Archive for Clinical and Experimental Ophthalmology (2007)